NF-κB in acute pancreatitis: Mechanisms and therapeutic potential

Pancreatology

Volumn 16, Issue 4, 2016, Pages 477-488

  Jakkampudi, Aparna ^a   Jangala, Ramaiah ^a   Reddy, B Ratnakar ^a   Mitnala, Sasikala ^a   Reddy, D Nageshwar ^b   Talukdar, Rupjyoti ^a,b  

^a Asian Healthcare Foundation   (India)

^b ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

Author keywords

Acute pancreatitis; Clinical implications; Cytokines; I B; NF B; Nuclear factor kappa B

Indexed keywords

CALPAIN 1 INHIBITOR; CYSTEINE PROTEINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEASOME INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; UNCLASSIFIED DRUG; CYTOKINE; I KAPPA B;

ACUTE PANCREATITIS; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INCIDENCE; INFLAMMATION; MEDIATOR RELEASE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; GENETICS; METABOLISM; PANCREATITIS, ACUTE NECROTIZING;

CYTOKINES; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PANCREATITIS, ACUTE NECROTIZING;

EID: 84973539303     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2016.05.001     Document Type: Review

References (86)

1. [1] Petrov, M.S., Shanbhag, S., Chakraborty, M., Phillips, A.R., Windsor, J.A., Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 139 (2010), 813–820.
2. [2] Banks, P.A., Bollen, T.L., Dervenis, C., Gooszen, H.G., Johnson, C.D., Sarr, M.G., et al., Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 62 (2013), 102–111.
3. [3] Satoh, A., Masamune, A., Kimura, K., Kaneko, K., Sakai, Y., Yamagiwa, T., et al. Nuclear factor kappa B expression in peripheral blood mononuclear cells of patients with acute pancreatitis. Pancreas 26 (2003), 350–356.
4. [4] Dambrauskas, Z., Giese, N., Gulbinas, A., Giese, T., Berberat, P.O., Pundzius, J., et al. Different profiles of cytokine expression during mild and severe acute pancreatitis. World J Gastroenterol 16 (2010), 1845–1853.
5. [5] Hoesel, B., Schmid, J.A., The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer, 12, 2013, 86.
6. [6] Sen, R., Baltimore, D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986), 705–716.
7. [7] Caamaño, J., Hunter, C.A., NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15 (2002), 414–429.
8. [8] Hayden, M.S.M., Ghosh, S.S., NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26 (2012), 203–234.
9. [9] Marienfeld, R., RelB forms transcriptionally inactive complexes with RelA/p65. J Biol Chem 278 (2003), 19852–19860.
10. [10] Birbach, A., Gold, P., Binder, B.R., Hofer, E., De Martin, R., Schmid, J.A., Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem 277 (2002), 10842–10851.
11. [11] Tan, P., Fuchs, S.Y., Chen, A., Wu, K., Gomez, C., Ronai, Z., et al. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell 3 (1999), 527–533.
12. [12] Hayden, M.S., Ghosh, S., Shared principles in NF-kappa B signaling. Cell 132 (2008), 344–362.
13. [13] Perkins, N.D., Integrating cell-signaling pathways with NF-kappa B and IKK function. Nat Rev Mol Cell Biol 8 (2007), 49–62.
14. [14] Sun, S.C., Non-canonical NF-κB signaling pathway. Cell Res 21 (2010), 71–85.
15. [15] Tieri, P., Termanini, A., Bellavista, E., Salvioli, S., Capri, M., Franceschi, C., Charting the NF-κB pathway interactome map. PLoS One, 7, 2012, e32678.
16. [16] Latimer, M., Ernst, M.K., Dunn, L.L., Drutskaya, M., Rice, N.R., The N-terminal domain of I kappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers. Mol Cell Biol 18 (1998), 2640–2649.
17. [17] Wertz, I.E., O'Rourke, K.M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., et al. Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappa B signaling. Nature 430 (2004), 694–699.
18. [18] Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., Mosialos, G., CYLD is a deubiquitinating enzyme that negatively regulates NF-kappa B activation by TNFR family members. Nature 424 (2003), 793–796.
19. [19] Altavilla, D., Famulari, C., Passaniti, M., Galeano, M., Macrì, A., Seminara, P., et al. Attenuated caerulein-induced pancreatitis in nuclear factor-kappaB-deficient mice. Lab Invest 83 (2003), 1723–1732.
20. [20] Sah, R.P., Saluja, A., Molecular mechanisms of pancreatic injury. Curr Opin Gastroenterol 27 (2011), 444–451.
21. [21] Sah, R.P., Dawra, R.K., Saluja, A.K., New insights into the pathogenesis of pancreatitis. Curr Opin Gastroenterol 29 (2013), 523–530.
22. [22] Steinle, A.U., Weidenbach, H., Wagner, M., Adler, G., Schmid, R.M., NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology 116 (1999), 420–430.
23. 2+ and protein kinase C as messengers. Am J Physiol 277 (1999), 678–686.
24. 2+ signaling and pancreatitis: effects of alcohol, bile and coffee. Trends Pharmacol Sci 27 (2006), 113–120.
25. 2+ signal generation and pancreatitis. Cell Calcium 45 (2009), 634–642.
26. [26] Muili, K.A., Jin, S., Orabi, A.I., Eisses, J.F., Javed, T.A., Le, T., et al. Pancreatic acinar cell nuclear factor kB activation because of bile acid exposure is dependent on calcineurin. J Biol Chem, 2013, 288 21065-73.
27. 2+activated ion channels in exocrine acinar cells. Cell Calcium 38 (2005), 171–200.
28. 2+release from both the endoplasmic reticulum and acidic intracellular calcium stores through activation of inositol triphosphate receptors and ryanodine receptors. J Biol Chem 281 (2006), 40154–40163.
29. [29] Muili, K.A., Ahmad, M., Orabi, A.I., Mahmood, S.M., Shah, A.U., Molkentin, J.D., et al. Pharmacological and genetic inhibition of calcineurin protects against carbachol-induced pathological zymogen activation and acinar cell injury. Am J Physiol Gastrointest Liver Physiol, 302, 2012 G898–G905.
30. [30] Rusnak, F., Mertz, P., Calcineurin. Form and function. Physiol Rev 80 (2000), 1483–1521.
31. [31] Awla, D., Zetterqvist, A.V., Abdulla, A., Camello, C., Berglund, L.M., Spégel, P., et al. NFATc3 regulates trypsinogen activation, neutrophil recruitment, and tissue damage in acute pancreatitis in mice. Gastroenterology 143 (2012), 1352–1360.
32. [32] Ramnath, R.D., Sun, J., Adhikari, S., Zhi, L., Bhatia, M., Role of PKC-δ on substance P-induced chemokine synthesis in pancreatic acinar cells. Am J Physiol Cell Physiol 294 (2008), 683–692.
33. [33] Liu, W.S., Heckman, C.A., The sevenfold way of PKC regulation. Cell Signal 10 (1998), 529–542.
34. [34] Pollo, D.A., Baldassare, J.J., Honda, T., Henderson, P.A., Talkad, V.D., Gardner, J.D., Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini. Biochim Biophys Acta 1224 (1994), 127–138.
35. [35] Bastani, B., Yang, L., Baldassare, J.J., Pollo, D.A., Gardner, J.D., Cellular distribution of isoforms of protein kinase C (PKC) in pancreatic acini. Biochim Biophys Acta 1269 (1995), 307–315.
36. [36] Yuan, J.Z., Lugea, A., Zheng, L., Gukovsky, I., Edderkaoui, M., Rozengurt, E., et al. Protein kinase D1 mediates NF-κB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 295 (2008), 1190–1201.
37. [37] Thrower, E.C., Wang, J., Cheriyan, S., Lugea, A., Kolodecik, T.R., Yuan, J., et al. Protein kinase C delta-mediated processes in cholecystokinin-8-stimulated pancreatic acini. Pancreas 38 (2009), 930–935.
38. [38] Satoh, A., Gukovskaya, A.S., Nieto, J.M., Cheng, J.H., Gukovsky, I., Reeve, J.R. Jr., et al. PKC-delta and - epsilon regulate NF-κB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 287 (2004), 582–591.
39. [39] Schulz, H.U., Niederau, C., Klonowski-Stumpe, H., Halangk, W., Luthen, R., Lippert, H., Oxidative stress in acute pancreatitis. Hepatogastroenterology 46 (1999), 2736–2750.
40. [40] Tsai, K., Wang, S.S., Chen, T.S., Kong, C.W., Chang, F.Y., Lee, S.D., et al. Oxidative stress: an important phenomenon with pathogenetic significance in the progression of acute pancreatitis. Gut 42 (1998), 850–855.
41. [41] Booth, D.M., Mukherjee, R., Sutton, R., Criddle, D.N., Calcium and reactive oxygen species in acute pancreatitis: friend or foe?. Antioxid Redox Signal 15 (2011), 2683–2698.
42. [42] Chernyak, B.V., Bernardi, P., The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur J Biochem 238 (1996), 623–630.
43. 2+ in pancreatic cell death induced by alcohol metabolites. J Gastroenterol Hepatol 21 (2006), 14–17.
44. [44] Booth, D.M., Murphy, J.A., Mukherjee, R., Awais, M., Neoptolemos, J.P., Gerasimenko, O.V., et al. Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells. Gastroenterology 140 (2011), 2116–2125.
45. [45] Voronina, S., Longbottom, R., Sutton, R., Petersen, O.H., Tepikin, A., Bile acids induce calcium signals in mouse pancreatic acinar cells: implications for bile-induced pancreatic pathology. J Physiol 540 (2002), 49–55.
46. [46] Mercurio, F., Manning, A.M., NF-kappa B as a primary regulator of the stress response. Oncogene 18 (1999), 6163–6171.
47. [47] Zhang, M.S., Zhang, K.J., Zhang, J., Jiao, X.L., Chen, D., Zhang, D.L., Phospholipases A-II (PLA2-II) induces acute pancreatitis through activation of the transcription factor NF-kappa B. Eur Rev Med Pharmacol Sci 18 (2014), 1163–1169.
48. [48] Viterbo, D., Bluth, M.H., Lin, Y.Y., Mueller, C.M., Wadgaonkar, R., Zenilman, M.E., Pancreatitis-associated protein 2 modulates inflammatory responses in macrophages. J Immunol 181 (2008), 1948–1958.
49. [49] Virlos, I., Mazzon, E., Serraino, I., Genovese, T., Di Paola, R., Thiemerman, C., et al. Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis. Intensive Care Med 30 (2004), 1645–1651.
50. [50] Pandol, S.J., Periskic, S., Gukovsky, I., Zaninovic, V., Jung, Y., Zong, Y., et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology 117 (1999), 706–716.
51. [51] Rakonczay, Z. Jr., Hegyi, P., Takács, T., McCarroll, J., Saluja, A.K., The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut 57 (2008), 259–267.
52. [52] Gukovskaya, A.S., Mouria, M., Gukovsky, I., Reyes, C.N., Kasho, V.N., Faller, L.D., et al. Ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats. Gastroenterology 122 (2002), 106–118.
53. [53] Rakonczay, Z. Jr., Jármay, K., Kaszaki, J., Mándi, Y., Duda, E., Hegyi, P., et al. NF-kappaB activation is detrimental in arginine-induced acute pancreatitis. Free Radic Biol Med 34 (2003), 696–709.
54. [54] Ramnath, R.D., Sun, J., Bhatia, M., Role of calcium in substance P-induced chemokine synthesis in mouse pancreatic acinar cells. Br J Pharmacol 154 (2008), 1339–1348.
55. [55] Telek, G., Ducroc, R., Scoazec, J.Y., Pasquier, C., Feldmann, G., Rozé, C., Differential up regulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis. J Surg Res 96 (2001), 56–57.
56. [56] Kempuraj, D., Twait, E.C., Williard, D.E., Yuan, Z., Meyerholz, D.K., Samuel, I., The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice. PLoS One, 8, 2013, e56866.
57. [57] Gea-Sorlí, S., Closa, D., In vitro, but not in vivo, reversibility of peritoneal macrophages activation during experimental acute pancreatitis. BMC Immunol, 10, 2009, 42.
58. [58] Vassalli, P., The pathophysiology of tumor necrosis factors. Ann Rev Immunol 10 (1992), 411–452.
59. [59] Matthew, S.H., Ghosh, S., Regulation of NF-κB by TNF family cytokines. Semin Immunol 26 (2014), 253–266.
60. [60] Heller, R.A., Krönke, M., Tumor necrosis factor receptor mediated signaling pathways. J Cell Biol 126 (1994), 5–9.
61. [61] Satoh, A., Gukovskaya, A.S., Edderkaoui, M., Daghighian, M.S., Reeve, J.R. Jr., Shimosegawa, T., et al. Tumor necrosis factor-α mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosinekinase 2. Gastroenterology 129 (2005), 639–651.
62. [62] Laster, S.N., Wood, J.G., Goding, L.R., Tumor necrosis factor can induce both apoptotic and necrotic form of cell lysis. J Immunol 141 (1988), 2629–2634.
63. [63] Denham, W., Yang, J., Fink, G., Denham, D., Carter, G., Bowers, V., et al. TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: a study in the perfused human pancreas. J Surg Res 74 (1998), 3–7.
64. [64] Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellino, M., Che, J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999), 248–251.
65. [65] Wang, H., Yang, H., Czura, C.J., Sama, A.E., Tracey, K.J., HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164 (2001), 1768–1773.
66. [66] Wang, H., Ward, M.F., Sama, A.E., Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32 (2009), 348–357.
67. [67] Harris, H.E., Andersson, U., Pisetsky, D.S., HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8 (2012), 195–202.
68. [68] Yasuda, T., Ueda, T., Takeyama, Y., Shinzeki, M., Sawa, H., Nakajima, T., et al. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 33 (2006), 359–363.
69. [69] Yang, Z.Y., Ling, Y., Yin, T., Tao, J., Xiong, J.X., Wu, H.S., et al. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. World J Gastroenterol 14 (2008), 4546–4550.
70. [70] Yang, H., Wang, H., Czura, C.J., Tracey, K.J., The cytokine activity of HMGB1. J Leukoc Biol 78 (2005), 1–8.
71. [71] Schmidt, A.M., Yan, S.D., Yan, S.F., Stern, D.M., The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498 (2000), 99–111.
72. [72] Taguchi, A., Blood, D.C., del Toro, G., Canet, A., Lee, D.C., Qu, W., et al. Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases. Nature 405 (2000), 354–360.
73. [73] Han, B., Ji, B., Logsdon, C.D., CCK independently activates intracellular trypsinogen and NF-kappaB in rat pancreatic acinar cells. Am J Physiol Cell Physiol 280 (2001), 465–472.
74. [74] Dawra, R., Sah, R.P., Dudeja, V., Rishi, L., Talukdar, R., Garg, P., et al. Intra-acinar trypsinogen activation mediates early stages of pancreatic injury but not inflammation in mice with acute pancreatitis. Gastroenterology 141 (2011), 2210–2217.
75. [75] Saluja, A.K., Saluja, M., Printz, H., Zavertnik, A., Sengupta, A., Steer, M.L., Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci U. S. A 86 (1989), 8968–8971.
76. [76] Seok, J., Warren, H.S., Cuenca, A.G., Mindrinos, M.N., Baker, H.V., Xu, W., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U. S. A 110 (2013), 3507–3512.
77. [77] Takao, K., Miyakawa, T., Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U. S. A 112 (2015), 1167–1172.
78. [78] Noel, P., Patel, K., Durgampudi, C., Trivedi, R.N., de Oliveira, C., Crowell, M.D., et al. Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections. Gut 65 (2016), 100–111.
79. [79] Schneider, C.P., Schwacha, M.G., Chaudry, I.H., Influence of gender and age on T-cell responses in a murine model of trauma-hemorrhage: differences between circulating and tissue-fixed cells. J Appl Physiol 100 (2006), 826–833.
80. [80] Mestas, J., Hughes, C.C., Of mice and not men: differences between mouse and human immunology. J Immunol 172 (2004), 2731–2738.
81. [81] Waters, J.A., Matos, J., Yip-Schneider, M., Aguilar-Saavedra, J.R., Crean, C.D., Beane, J.D., et al. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts. Surgery 158 (2015), 881–888.
82. [82] Yu, H., Guo, C., Feng, B., Liu, J., Chen, X., Wang, D., et al. Triple-layered pH-responsive micelleplexes loaded with siRNA and cisplatin prodrug for NF-Kappa B targeted treatment of metastatic breast cancer. Theranostics 6 (2016), 14–27.
83. [83] Zhou, H.F., Yan, H., Pan, H., Hou, K.K., Akk, A., Springer, L.E., et al. Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. J Clin Invest 124 (2014), 4363–4374.
84. [84] Wan, H., Yuan, Y., Qian, A., Sun, Y., Qiao, M., Pioglitazone, a PPAR gamma ligand, suppresses NF-kappaB activation through inhibition of IkappaB kinase activation in caerulein-treated AR42J cells. Biomed Pharmacother 62 (2008), 466–472.
85. [85] Jiang, C.Y., Wang, W., Tang, J.X., Yuan, Z.R., The adipocytokine resistin stimulates the production of proinflammatory cytokines TNF-α and IL-6 in pancreatic acinar cells via NF-κB activation. J Endocrinol Invest 36 (2013), 986–992.
86. [86] Tang, Y., Han, Y., Liu, L., Shen, W., Zhang, H., Wang, Y., et al. Protective effects and mechanisms of G5 PAMAM dendrimers against acute pancreatitis induced by caerulein in mice. Biomacromolecules 16 (2015), 174–182.